Rani Therapeutics Holdings, Inc. - Class A Common Stock (RANI)
1.6400
+1.1700 (248.94%)
NASDAQ · Last Trade: Oct 18th, 9:30 AM EDT
Curious about the most active stocks on Friday? Find out which stocks are dominating the market action!
Via Chartmill · October 17, 2025
Via Benzinga · October 17, 2025
Via Benzinga · October 17, 2025
Via Benzinga · October 17, 2025
Rani Therapeutics (NASDAQ: RANI) stock surged on licensing collaboration with Chugai and $60.3M private placement. RANI up 191.99% at $1.375.
Via Benzinga · October 17, 2025
Before the US market kicks off on Friday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
Via Chartmill · October 17, 2025
Via Benzinga · October 17, 2025
The total potential payments from the collaboration could reach $1.085 billion if all options are exercised.
Via Stocktwits · October 17, 2025
Gainers Galecto (NASDAQ: GLTO) stock rose 21.6% to $5.41 during Thursday's after-market session. The market value of their outstanding shares is at $5.6 million.
Via Benzinga · September 25, 2025
Via Benzinga · August 27, 2025
Wondering how the US markets performed in the middle of the day on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis.
Via Chartmill · July 15, 2025
Via Benzinga · July 15, 2025
Let's have a look at what is happening on the US markets on Tuesday. Below you can find the gap up and gap down stocks in today's session.
Via Chartmill · July 15, 2025
Discover the top movers in Tuesday's pre-market session and stay informed about market dynamics.
Via Chartmill · July 15, 2025
Via Benzinga · July 15, 2025
Via Benzinga · July 14, 2025
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Via Chartmill · July 14, 2025
Traders are paying attention to the gapping stocks in Monday's session. Let's dive into which stocks are experiencing notable gaps.
Via Chartmill · July 14, 2025
Via Benzinga · July 14, 2025
Via Benzinga · July 14, 2025